# Assessing the nutritional value and health risks of special low‑protein foods: narrative review

**Authors:** Maryam Ziadlou, Anita MacDonald

PMC · DOI: 10.1186/s13023-026-04266-w · 2026-03-06

## TL;DR

This paper reviews low-protein foods used for metabolic disorders, highlighting their benefits and potential health risks, and suggests natural alternatives to improve nutrition.

## Contribution

The paper proposes exploring natural plant-based alternatives to enhance the nutritional quality and health outcomes of low-protein foods.

## Key findings

- SLPFs are crucial for managing inherited amino acid disorders but may cause gut dysbiosis and cardio-metabolic risks.
- Natural plant sources could improve SLPFs' nutritional quality and reduce adverse effects.
- Hydrocolloid fibers in SLPFs may suppress gut microbiota and contribute to obesity.

## Abstract

Special low-protein foods (SLPFs) are essential for patients with disorders of inherited amino acid metabolism that require lifelong dietary protein restriction to prevent severe neurocognitive effects and even death. Conditions such as phenylketonuria (PKU), tyrosinemia (TYR), maple syrup urine disease (MSUD), homocystinuria (HCU), and urea cycle disorders (UCD) depend on these foods to support metabolic control and dietary adherence. SLPFs provide satiety, energy, and help prevent catabolism, but their nutritional composition poses challenges. Most SLPFs are formulated using isolated starches as the primary macronutrient base. Hydrocolloid fibers are commonly added to improve texture, consistency, shelf life, and water or gas retention. These ingredients form the backbone of SLPFs production and are consistently used across different regions worldwide, reflecting a standardized approach to their formulation. However, their potential adverse effects include suppression of gut microbiota, gut dysbiosis, increased inflammatory markers, overweight, and obesity, all of which raise cardio‑metabolic risks. Strengthening the nutritional quality of SLPFs through natural plant sources may help mitigate their potential adverse outcomes while ensuring patients’ dietary needs are met. Therefore, it is important to explore natural low‑protein alternatives that can both support sustainable food production and promote long‑term health benefits.

## Linked entities

- **Diseases:** phenylketonuria (MONDO:0009861), tyrosinemia (MONDO:0004741), maple syrup urine disease (MONDO:0009563), homocystinuria (MONDO:0004737), urea cycle disorders (MONDO:0004739)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}
- **Diseases:** vascular dysfunction (MESH:D002561), glycogen storage disease type 1 (MESH:D006008), IR (MESH:D007333), Crohn's disease (MESH:D003424), CVD (MESH:D002318), gastrointestinal dysfunction (MESH:D005767), ADHD (MESH:D001289), vascular stiffness (MESH:C566112), intellectual disability (MESH:D008607), brain toxicity (MESH:D001927), hypertension (MESH:D006973), nutritional deficiencies (MESH:D044342), carcinogenic (MESH:D011230), eczema (MESH:D004485), death (MESH:D003643), colon cancer (MESH:D015179), atherosclerosis (MESH:D050197), UCD (MESH:D056806), cardio (MESH:D059347), Propionic acidemia (MESH:D056693), neurological impairment (MESH:D009422), cognitive decline (MESH:D003072), ulcerative colitis (MESH:D003093), abdominal obesity (MESH:D056128), impaired glucose tolerance (MESH:D018149), fungal infections (MESH:D009181), rotavirus diarrhea (MESH:D012400), SLPFs (MESH:D009800), AMDs (MESH:D000592), allergic reactions (MESH:D004342), type 2 diabetes (MESH:D003924), HCU (MESH:D006712), musculoskeletal diseases (MESH:D009140), kidney dysfunction (MESH:D007674), IBD (MESH:D015212), HPA (MESH:D010661), depression (MESH:D003866), irritability (MESH:D001523), Alzheimer's disease (MESH:D000544), neurotoxicity (MESH:D020258), dysbiosis (MESH:D064806), endothelial dysfunction (MESH:D014652), Diabetes (MESH:D003920), cancer (MESH:D009369), AMD (MESH:D006009), Dyslipidemia (MESH:D050171), PA (MESH:C535387), TMAO (MESH:D028361), neurodegenerative disease (MESH:D019636), inflammation (MESH:D007249), Metabolic syndrome (MESH:D024821), metabolic (MESH:D008659), CMC (MESH:C535434), overweight (MESH:D050177), colon carcinogenesis (MESH:D063646), TYR (MESH:D020176), MSUD (MESH:D008375), obesity (MESH:D009765)
- **Chemicals:** Starch (MESH:D013213), riboflavin (MESH:D012256), Phe (MESH:D010649), MUFAs (MESH:D005229), Arabic gum (MESH:D006170), Carbohydrate (MESH:D002241), SFAs (MESH:D005227), Oil (MESH:D009821), Butyrate (MESH:D002087), MSG (MESH:D012970), amino acid (MESH:D000596), PUFAs (MESH:D005231), oligosaccharides (MESH:D009844), sodium (MESH:D012964), betalains (MESH:D050858), DATEM (-), curcumin (MESH:D003474), glucose (MESH:D005947), magnesium (MESH:D008274), bioflavonoids (MESH:D005419), Quinoline Yellow (MESH:C019303), monoglycerides (MESH:D050178), SCFA (MESH:D005232), carob (MESH:C017471), cellulose (MESH:D002482), anthocyanins (MESH:D000872), sucrose (MESH:D013395), lipid (MESH:D008055), propylene glycol alginate (MESH:C038550), fructose (MESH:D005632), E412 (MESH:C007894), Polyphenol (MESH:D059808), Prebiotics (MESH:D056692), CMC (MESH:D002266), TG (MESH:D014280), HPMC (MESH:D065347), chlorophylls (MESH:D002734), Fructooligosaccharides (MESH:C116580), E414 (MESH:C111140), lactose (MESH:D007785), polysaccharides (MESH:D011134), Sugar (MESH:D000073893), Salt (MESH:D012492), Maltodextrin (MESH:C008315), TMAO (MESH:C005855), Carrageenan (MESH:D002351), zinc (MESH:D015032), fat (MESH:D005223), Tartrazine (MESH:D013645), E415 (MESH:C002563), cholesterol (MESH:D002784), galactose (MESH:D005690), Sunset Yellow (MESH:C005842), glucosinolates (MESH:D005961), alkaloids (MESH:D000470), iron (MESH:D007501), catechins (MESH:D002392), Allura Red (MESH:C005915), Palm oil (MESH:D000073878), apigenin (MESH:D047310)
- **Species:** Bifidobacterium (genus) [taxon 1678], Homo sapiens (human, species) [taxon 9606], Faecalibacterium prausnitzii (species) [taxon 853], Hibiscus (rosemallows, genus) [taxon 47605], Daucus carota (carrot, species) [taxon 4039], Akkermansia muciniphila (species) [taxon 239935], gut metagenome (species) [taxon 749906], Bacteroidia (class) [taxon 200643], Phocaeicola vulgatus (species) [taxon 821], Bos taurus (bovine, species) [taxon 9913], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Curcuma longa (turmeric, species) [taxon 136217], Solanum tuberosum (potatoes, species) [taxon 4113], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Musa acuminata (banana, species) [taxon 4641], Lactobacillus (genus) [taxon 1578], Prevotella (genus) [taxon 838], Mus musculus (house mouse, species) [taxon 10090], Malus domestica (apple, species) [taxon 3750], Meleagris gallopavo (common turkey, species) [taxon 9103], Ruminococcus bromii (species) [taxon 40518], Roseburia (genus) [taxon 841], Mangifera indica (mango, species) [taxon 29780]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965038/full.md

---
Source: https://tomesphere.com/paper/PMC12965038